松下弘道

マツシタヒロミチ | Matsushita Hiromichi

所属機関・部署：
職名：教授

研究分野 (2件)：その他 , 血液、腫瘍内科学

研究キーワード (2件)：臨床検査医学 , 白血病

競争的資金等の研究課題 (8件)：

全件表示

論文 (111件)：

Hiroki Inoue, Taku Kanda, Gakuto Hayashi, Ryota Munenaga, Masayuki Yoshida, Kana Hasegawa, Takuya Miyagawa, Yukiya Kurumada, Jumpei Hasegawa, Tomoyuki Wada, et al. A MAP1B-cortactin-Tks5 axis regulates TNBC invasion and tumorigenesis. The Journal of cell biology. 2024. 223. 3
Yoshifumi Uwamino, Kengo Nagashima, Ayumi Yoshifuji, Shigeru Suga, Mizuho Nagao, Takao Fujisawa, Munekazu Ryuzaki, Yoshiaki Takemoto, Ho Namkoong, Masatoshi Wakui, et al. Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination. npj Vaccines. 2023. 8. 1
Masayuki Komatsu, Hitoshi Ichikawa, Fumiko Chiwaki, Hiromi Sakamoto, Rie Komatsuzaki, Makoto Asaumi, Kazuhisa Tsunoyama, Takeo Fukagawa, Hiromichi Matsushita, Narikazu Boku, et al. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer. Oncogene. 2022
Suguru Fukuhara, Yuji Oshikawa-Kumade, Yasunori Kogure, Sumito Shingaki, Hirokazu Kariyazono, Yoshiya Kikukawa, Junji Koya, Yuki Saito, Mariko Tabata, Kota Yoshifuji, et al. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies. Cancer science. 2022. 113. 8. 2763-2777
Naoki Kojima, Yasuhito Arai, Kaishi Satomi, Takashi Kubo, Yuko Matsushita, Taisuke Mori, Hiromichi Matsushita, Toshikazu Ushijima, Yasushi Yatabe, Tatsuhiro Shibata, et al. Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall. MODERN PATHOLOGY. 2022

MISC (61件)：

片平泰弘, 樋口廣士, 山本雄一郎, 安藤潔, 幸谷愛, 松下弘道, 八幡崇, 小池亮, 佐藤克明, 今留謙一, et al. Increased Granulopoiesis in the Bone Marrow following Epstein-Barr Virus Infection(和訳中). 東京医科大学雑誌. 2020. 78. 3. 290-291
Hidetsugu Kawai, Hiromichi Matsushita, Yasuyuki Aoyama, Keiko Matsui, Makoto Onizuka, Kiyoshi Ando. Dysplastic features seen in a patient with acute myeloid leukemia harboring the KTM2A-TET1 fusion gene. International Journal of Hematology. 2018. 108. 1
若井進, 柿島裕樹, 山口佳織, 角南久仁子, 古田耕, 吉田朗彦, 松下弘道. FISH検査後のスライド標本からの再染色(Reprobing)に関する検討. 臨床病理. 2017. 65. 補冊. 242-242
Matsushita Hiromichi, Kawai Hidetsugu, Tanaka Masayuki, Harada Hironori, Harada Yuka, Amaki Jun, Sheng Yin, Shiina Takashi, Onizuka Makoto, Ando Kiyoshi. 急性骨髄性白血病に対するターゲットシークエンスパネル(Targeted next-generation sequencing in acute myeloid leukemia). 臨床血液. 2017. 58. 9. 1514-1514
松下弘道. 悪性リンパ腫(CLL,ATL,GLPD/LGLを除く) (特集リンパ球の増減を正しく評価するために). 臨床検査 = Journal of clinical laboratory medicine. 2017. 61. 8. 984-991

書籍 (5件)：

松下弘道、宮地勇人. 乳酸アシドーシス: がん救急マニュアル
大江裕一郎、新海哲、高橋俊二編、メジカルビュー社、東京 2011
M. Kizaki, H. Matsushita and Y. Ikeda. Therapeutic applications of ribozymes for leukemic cells with t(8;21) and the mechanism of their anti-leukemic effect. Bio Techniques Books: Ribozyme Biochemistry and Biotechnology
(Ed) Krupp G, Eaton Publishing, Natick, MA 2000
M. Kizaki, H. Matsushita and Y. Ikeda. Therapeutic applications of ribozymes for leukemic cells with t(8;21) and the mechanism of their anti-leukemic effect. Bio Techniques Books: Ribozyme Biochemistry and Biotechnology
(Ed) Krupp G, Eaton Publishing, Natick, MA 2000
Matsushita H, Kobayashi H, Mori S, Kizaki M, Ikeda Y: Ribozyme targeted against AML1/MTG8: Evaluation of ribozyme efficiency in a cell-free system and transfection with cationic liposome.
Methods in Molecular Medicine, vol 11: Therapeutic applications of ribozymes(Ed) Scanlon KJ, Humana Press Inc., Totowa, NJ 1998
Matsushita H, Kobayashi H, Mori S, Kizaki M, Ikeda Y: Ribozyme targeted against AML1/MTG8: Evaluation of ribozyme efficiency in a cell-free system and transfection with cationic liposome.
Methods in Molecular Medicine, vol 11: Therapeutic applications of ribozymes(Ed) Scanlon KJ, Humana Press Inc., Totowa, NJ 1998

学歴 (2件)：

学位 (1件)：

経歴 (8件)：

全件表示

所属学会 (9件)：

American Society of Hematology , 日本癌学会 , 日本内科学会 , 日本臨床検査医学会 , 日本血液学会 , 日本臨床微生物学会 , 日本臨床化学会 , 日本医療検査科学会 , 日本検査血液学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

松下 弘道